Real-World Evaluation of Letermovir Use in Kidney Transplant Recipients: Drug Interactions, Safety, and Impact on Renal Function.

Prevymis (letermovir) - Merck (MSD)

Real-World Evaluation of Letermovir Use in Kidney Transplant Recipients: Drug Interactions, Safety, and Impact on Renal Function. (PubMed, Transpl Int) - Dec 22, 2025 - No abstract available
HEOR • Journal • Real-world evidence • Cytomegalovirus Infection • Transplantation

http://www.ncbi.nlm.nih.gov/pubmed/41424458

Betoul Schvartz; Charlotte Boud'hors; Clément Danthu; Cyril Garrouste; Dominique Bertrand; Florence Runyo; Gauthier Flahaut; Ilies Benotmane; Sophie Caillard

Dec 22, 2025